Abstract |
Efforts are currently underway to develop a vaccine against Clostridium difficile infection (CDI). We developed two decision analytic Monte Carlo computer simulation models: (1) an Initial Prevention Model depicting the decision whether to administer C. difficile vaccine to patients at-risk for CDI and (2) a Recurrence Prevention Model depicting the decision whether to administer C. difficile vaccine to prevent CDI recurrence. Our results suggest that a C. difficile vaccine could be cost-effective over a wide range of C. difficile risk, vaccine costs, and vaccine efficacies especially, when being used post-CDI treatment to prevent recurrent disease.
|
Authors | Bruce Y Lee, Michael J Popovich, Ye Tian, Rachel R Bailey, Paul J Ufberg, Ann E Wiringa, Robert R Muder |
Journal | Vaccine
(Vaccine)
Vol. 28
Issue 32
Pg. 5245-53
(Jul 19 2010)
ISSN: 1873-2518 [Electronic] Netherlands |
PMID | 20541582
(Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
|
Copyright | (c) 2010 Elsevier Ltd. All rights reserved. |
Chemical References |
|
Topics |
- Bacterial Vaccines
(administration & dosage, economics)
- Clostridioides difficile
- Computer Simulation
- Cost-Benefit Analysis
- Enterocolitis, Pseudomembranous
(prevention & control)
- Humans
- Models, Economic
- Monte Carlo Method
- Risk Factors
- Secondary Prevention
|